Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II)

Daisy D. De León, Nadia N Laack, Stephanie Nainani, Yayesh Asmerom

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We previously demonstrated that expression of IGF-II modulates the routing of cathepsin D in MCF-7 cells. In our present study, we transfected antisense IGF-II into IGF-II secreting MCF-7 cells to test the hypothesis that blocking IGF-II may reduce the secretion of cathepsin D in breast cancer cells. The concentration of IGF-II in media conditioned by the antisense clone was reduced to almost undetectable levels. Likewise, Northern blotting analysis revealed that IGF-II mRNA was nearly undetectable in the antisense transfected cells. Metabolic labeling experiments performed with 10 mM mannose 6-phosphate present in the medium to block reuptake of lysosomal enzymes demonstrated that cathepsin D secretion was dramatically reduced. Similarly, a significant reduction in cathepsin D was observed when conditioned media and cell extracts were examined by Western blotting after a 48 h incubation. No changes in cathepsin D mRNA in antisense cells were detected by Northern blot analysis. We conclude that endogenous IGF-II may modulate the routing of cathepsin D by interfering with receptor trafficking in MCF-7 cells, and that this modulation is reversible. Abnormally high levels of IGF-II may alter this homeostasis, conferring on breast cancer cells an advantageous mechanism that promotes rapid growth, and may faciliate metastasis.

Original languageEnglish (US)
Pages (from-to)142-147
Number of pages6
JournalHormone and Metabolic Research
Volume31
Issue number2-3
StatePublished - 1999
Externally publishedYes

Fingerprint

Cathepsin D
Insulin-Like Growth Factor II
Cells
Modulation
Breast Neoplasms
MCF-7 Cells
Conditioned Culture Medium
Northern Blotting
Messenger RNA
Cell Extracts
Labeling
Homeostasis
Clone Cells
Western Blotting
Neoplasm Metastasis
Enzymes
Growth

Keywords

  • Breast cancer
  • Cathepsin D
  • IGF-II/Mannose 6- phosphate receptor
  • Insulin-like growth factor II (IGF-II)
  • MCF-7 cells

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II). / De León, Daisy D.; Laack, Nadia N; Nainani, Stephanie; Asmerom, Yayesh.

In: Hormone and Metabolic Research, Vol. 31, No. 2-3, 1999, p. 142-147.

Research output: Contribution to journalArticle

@article{d7c94cf5fb8d423bb6b1539c477d57e2,
title = "Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II)",
abstract = "We previously demonstrated that expression of IGF-II modulates the routing of cathepsin D in MCF-7 cells. In our present study, we transfected antisense IGF-II into IGF-II secreting MCF-7 cells to test the hypothesis that blocking IGF-II may reduce the secretion of cathepsin D in breast cancer cells. The concentration of IGF-II in media conditioned by the antisense clone was reduced to almost undetectable levels. Likewise, Northern blotting analysis revealed that IGF-II mRNA was nearly undetectable in the antisense transfected cells. Metabolic labeling experiments performed with 10 mM mannose 6-phosphate present in the medium to block reuptake of lysosomal enzymes demonstrated that cathepsin D secretion was dramatically reduced. Similarly, a significant reduction in cathepsin D was observed when conditioned media and cell extracts were examined by Western blotting after a 48 h incubation. No changes in cathepsin D mRNA in antisense cells were detected by Northern blot analysis. We conclude that endogenous IGF-II may modulate the routing of cathepsin D by interfering with receptor trafficking in MCF-7 cells, and that this modulation is reversible. Abnormally high levels of IGF-II may alter this homeostasis, conferring on breast cancer cells an advantageous mechanism that promotes rapid growth, and may faciliate metastasis.",
keywords = "Breast cancer, Cathepsin D, IGF-II/Mannose 6- phosphate receptor, Insulin-like growth factor II (IGF-II), MCF-7 cells",
author = "{De Le{\'o}n}, {Daisy D.} and Laack, {Nadia N} and Stephanie Nainani and Yayesh Asmerom",
year = "1999",
language = "English (US)",
volume = "31",
pages = "142--147",
journal = "Hormone and Metabolic Research",
issn = "0018-5043",
publisher = "Georg Thieme Verlag",
number = "2-3",

}

TY - JOUR

T1 - Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II)

AU - De León, Daisy D.

AU - Laack, Nadia N

AU - Nainani, Stephanie

AU - Asmerom, Yayesh

PY - 1999

Y1 - 1999

N2 - We previously demonstrated that expression of IGF-II modulates the routing of cathepsin D in MCF-7 cells. In our present study, we transfected antisense IGF-II into IGF-II secreting MCF-7 cells to test the hypothesis that blocking IGF-II may reduce the secretion of cathepsin D in breast cancer cells. The concentration of IGF-II in media conditioned by the antisense clone was reduced to almost undetectable levels. Likewise, Northern blotting analysis revealed that IGF-II mRNA was nearly undetectable in the antisense transfected cells. Metabolic labeling experiments performed with 10 mM mannose 6-phosphate present in the medium to block reuptake of lysosomal enzymes demonstrated that cathepsin D secretion was dramatically reduced. Similarly, a significant reduction in cathepsin D was observed when conditioned media and cell extracts were examined by Western blotting after a 48 h incubation. No changes in cathepsin D mRNA in antisense cells were detected by Northern blot analysis. We conclude that endogenous IGF-II may modulate the routing of cathepsin D by interfering with receptor trafficking in MCF-7 cells, and that this modulation is reversible. Abnormally high levels of IGF-II may alter this homeostasis, conferring on breast cancer cells an advantageous mechanism that promotes rapid growth, and may faciliate metastasis.

AB - We previously demonstrated that expression of IGF-II modulates the routing of cathepsin D in MCF-7 cells. In our present study, we transfected antisense IGF-II into IGF-II secreting MCF-7 cells to test the hypothesis that blocking IGF-II may reduce the secretion of cathepsin D in breast cancer cells. The concentration of IGF-II in media conditioned by the antisense clone was reduced to almost undetectable levels. Likewise, Northern blotting analysis revealed that IGF-II mRNA was nearly undetectable in the antisense transfected cells. Metabolic labeling experiments performed with 10 mM mannose 6-phosphate present in the medium to block reuptake of lysosomal enzymes demonstrated that cathepsin D secretion was dramatically reduced. Similarly, a significant reduction in cathepsin D was observed when conditioned media and cell extracts were examined by Western blotting after a 48 h incubation. No changes in cathepsin D mRNA in antisense cells were detected by Northern blot analysis. We conclude that endogenous IGF-II may modulate the routing of cathepsin D by interfering with receptor trafficking in MCF-7 cells, and that this modulation is reversible. Abnormally high levels of IGF-II may alter this homeostasis, conferring on breast cancer cells an advantageous mechanism that promotes rapid growth, and may faciliate metastasis.

KW - Breast cancer

KW - Cathepsin D

KW - IGF-II/Mannose 6- phosphate receptor

KW - Insulin-like growth factor II (IGF-II)

KW - MCF-7 cells

UR - http://www.scopus.com/inward/record.url?scp=0032951889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032951889&partnerID=8YFLogxK

M3 - Article

C2 - 10226795

AN - SCOPUS:0032951889

VL - 31

SP - 142

EP - 147

JO - Hormone and Metabolic Research

JF - Hormone and Metabolic Research

SN - 0018-5043

IS - 2-3

ER -